---
$id: https://graph.org.ai/products/commodity/51412014
$type: Product
source: UNSPSC
code: "51412014"
title: "Linsidomine hydrochloride"
class: "51412000"
classTitle: "Vasodilator azoles"
family: "51410000"
familyTitle: "Vasodilators"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Linsidomine hydrochloride

**UNSPSC Code**: 51412014
**Class**: [Vasodilator azoles](Vasodilator azoles.mdx)
**Family**: [Vasodilators](../Vasodilators.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vasodilating agent and nitric oxide-releasing compound with the molecular formula C6H10N4O2.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y0054U597M. European Medicines Agency schedules linsidomine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21667. The term linsidomine hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule linsidomine hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, LINSIDOMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1C(ON[N+]1N2CCOCC2)N.[CL-].

